Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
Jeffrey L. Cummings, Andrew A. Ortiz, Janelle Castellino, et al.
European Journal of Neuroscience (2022) Vol. 56, Iss. 9, pp. 5727-5757
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes
Michail Michailidis, Despina Μoraitou, Despina Α. Tata, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2687-2687
Open Access | Times Cited: 150
Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use
Anna Skrzypczak-Wiercioch, Kinga Sałat
Molecules (2022) Vol. 27, Iss. 17, pp. 5481-5481
Open Access | Times Cited: 132
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, et al.
Pharmacological Research (2022) Vol. 186, pp. 106550-106550
Open Access | Times Cited: 104
Cerebrovascular insulin receptors are defective in Alzheimer’s disease
Manon Leclerc, Philippe Bourassa, Cyntia Tremblay, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 75-90
Open Access | Times Cited: 54
State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease
Elizabeth M. Rhea, Manon Leclerc, Hussein N. Yassine, et al.
Aging and Disease (2023)
Open Access | Times Cited: 32
Mitochondria and Oxidative Stress as a Link between Alzheimer’s Disease and Diabetes Mellitus
Ivan M. Veselov, Daria V. Vinogradova, Andrey V. Maltsev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14450-14450
Open Access | Times Cited: 16
Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism
Waad A. Samman, Salma Selim, Hassan M. El Fayoumi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 753-753
Open Access | Times Cited: 15
A Systematic Review of Semaglutide’s Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies
Raluca Oana Tipa, Daniela-Gabriela Bălan, Mihai Géorgescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4972-4972
Open Access | Times Cited: 6
Pathogenesis, Diagnostics, and Therapeutics for Alzheimer's Disease: Breaking the Memory Barrier
Pushpa Tryphena Kamatham, Rashi K. Shukla, Dharmendra Kumar Khatri, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102481-102481
Open Access | Times Cited: 5
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease
María F. Colavitta, Francisco J. Barrantes
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2052-2052
Open Access | Times Cited: 12
Association between Modifiable Risk Factors and Levels of Blood-Based Biomarkers of Alzheimer’s and Related Dementias in the Look AHEAD Cohort
Kathleen M. Hayden, Michelle M. Mielke, J.K. Evans, et al.
Journal of Aging Research and Lifestyle (2024)
Open Access | Times Cited: 4
Diabetes Mellitus and Energy Dysmetabolism in Alzheimer’s Disease: Understanding the Relationships and Potential Therapeutic Targets
Adejoke Y. Onaolapo, Folusho O. Ojo, Olufunto O. Adeleye, et al.
Current Diabetes Reviews (2023) Vol. 19, Iss. 8
Closed Access | Times Cited: 8
Causal Relationship Between Basal Metabolic Rate and Alzheimer’s Disease: A Bidirectional Two-sample Mendelian Randomization Study
Yuexiao Zou, Qingxian Wang, Xiao‐Rui Cheng
Neurology and Therapy (2023) Vol. 12, Iss. 3, pp. 763-776
Open Access | Times Cited: 8
Role of Senescent Astrocytes in Health and Disease
Jacopo Meldolesi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8498-8498
Open Access | Times Cited: 8
Qingxin Kaiqiao Fang decreases Tau hyperphosphorylation in Alzheimer's disease via the PI3K/Akt/GSK3β pathway in vitro and in vivo
Shuo Liu, Luting Xu, Yan Shen, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117031-117031
Open Access | Times Cited: 8
Aging as a target for the prevention and treatment of Alzheimer’s disease
Lauren E. Yap, James E. Hunt, Raymond Scott Turner
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Diabetes and brain disorders, a new role for insulin?
Bastiaan E. de Galan
Neuroscience & Biobehavioral Reviews (2024) Vol. 163, pp. 105775-105775
Open Access | Times Cited: 2
Conquering Insulin Network Dysfunctions in Alzheimer’s Disease: Where Are We Today?
Suzanne M. de la Monte
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S317-S343
Closed Access | Times Cited: 2
Effectiveness of Chickpeas on Blood Sugar: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Taegwang Nam, Anna Kim, Yong-Taek Oh
Nutrients (2023) Vol. 15, Iss. 21, pp. 4556-4556
Open Access | Times Cited: 5
Irisin suppresses pancreatic β cell pyroptosis in T2DM by inhibiting the NLRP3-GSDMD pathway and activating the Nrf2-TrX/TXNIP signaling axis
Tianrong Li, Jingjing Yang, Anjun Tan, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Hypoglycemic TCM formulas (Huangqi-Gegen drug pair) have the potential as an Alzheimer's disease
Yang Hai, Ke Ren, Wenqian Hou, et al.
Phytomedicine (2024) Vol. 130, pp. 155723-155723
Closed Access | Times Cited: 1
Unraveling the Mechanisms of Hydrophilic Vitamins in Alzheimer’s and Parkinson’s: Preclinical and Clinical Evidence
Stuti Parab, Neel Parekh, Ketaki Apte, et al.
Advances in biochemistry in health and disease (2024), pp. 181-217
Closed Access | Times Cited: 1
Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration
Katherine O. Kopp, Yazhou Li, Elliot J. Glotfelty, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 872-872
Open Access | Times Cited: 1
Associations between the Use of Metformin and Behavioral and Psychological Symptoms in Patients with Alzheimer´s Disease, and Type 2 Diabetes Mellitus – A Register-based Study
Helena Kullenberg, Moa Wibom, Maria Kumlin, et al.
Current Alzheimer Research (2023) Vol. 20, Iss. 2, pp. 109-119
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top